K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation

NCT06127940 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Metastatic

Interventions

RADIATION: Stereotactic body radiation therapy (SBRT)
DRUG: Temporary Stopping

Sponsor

Karolinska University Hospital

Collaborators

[object Object]
[object Object]